Kamada Ltd. (KMDA) Financials

KMDA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 383.2 million 113.6 million
March 31, 2026 383.0 million 123.6 million
Dec. 31, 2025 378.8 million 109.7 million
Sept. 30, 2025 377.2 million 112.0 million

KMDA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 16.0 million ?
March 31, 2026 -1.3 million 800000
Dec. 31, 2025 5.0 million 458000
Sept. 30, 2025 6.8 million 117000

KMDA Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 9.3 million
March 31, 2026 4.1 million
Dec. 31, 2025 3.6 million
Sept. 30, 2025 5.3 million

KMDA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 70.1 million - 11.8 million
March 31, 2026 73.1 million - 11.6 million
Dec. 31, 2025 75.5 million - 9.4 million
Sept. 30, 2025 72.0 million - 11.5 million

KMDA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 57.9 million
March 31, 2026 59.0 million
Dec. 31, 2025 61.7 million
Sept. 30, 2025 58.8 million

KMDA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2.1 million 2.2 million 10.8 million 4.9 million
March 31, 2026 973000 2.2 million 10.0 million 4.8 million
Dec. 31, 2025 2.9 million 2.9 million 7.2 million -3.8 million
Sept. 30, 2025 3.6 million 2.6 million 9.3 million 4.5 million

KMDA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 54.9 million 32.5 million
March 31, 2026 45.2 million 26.1 million
Dec. 31, 2025 44.7 million 27.7 million
Sept. 30, 2025 47.0 million 27.2 million

KMDA

Price: $7.76

52 week price:
6.50
9.35

Dividend Yield: 5.05%

5-year range yield:
2.15%
5.05%

Forward Dividend Yield: 2.19%

Payout Ratio Range:
6.74%
357.14%

Dividend Per Share: 0.17 USD

Earnings Per Share: 0.38 USD

P/E Ratio: 20.76

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Israel

Volume: 40400

Ebitda: 7.4 million

Market Capitalization: 479.4 million

Average Dividend Frequency: 1

Years Paying Dividends: 1

Links: